Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Breaking Barriers to Effective Type 2 Diabetes Management: Findings from the use of the OPTIMA© Questionnaire in Clinical Practice.
Grimaldi A, Penfornis A, Consoli S, Falissard B, Eymard E, Williams P, Dejager S. Grimaldi A, et al. Among authors: dejager s. Adv Ther. 2016 Jun;33(6):1033-48. doi: 10.1007/s12325-016-0341-6. Epub 2016 May 18. Adv Ther. 2016. PMID: 27193870 Free PMC article. Clinical Trial.
A comprehensive description of muscle symptoms associated with lipid-lowering drugs.
Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G. Franc S, et al. Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):459-65. doi: 10.1023/b:card.0000015861.26111.ab. Cardiovasc Drugs Ther. 2003. PMID: 15107601
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.
Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S. Bruckert E, et al. Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):225-31. doi: 10.1111/j.1076-7460.2003.02000.x. Am J Geriatr Cardiol. 2003. PMID: 12888702 Clinical Trial.
[Hyperlipidemia in pregnancy].
Dejager S, Turpin G. Dejager S, et al. Presse Med. 1996 Nov 30;25(37):1839-45. Presse Med. 1996. PMID: 8991039 Review. French.
How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.
Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ, Peixoto O, Touboul C, Dubois C, Dejager S. Mosnier-Pudar H, et al. Diabetes Metab. 2009 Jun;35(3):220-7. doi: 10.1016/j.diabet.2009.02.001. Epub 2009 Mar 19. Diabetes Metab. 2009. PMID: 19303338
AIM: The main purpose of this survey was to describe type 2 diabetes (T2DM) from the patient's standpoint in a representative French panel in 2008. ...
AIM: The main purpose of this survey was to describe type 2 diabetes (T2DM) from the patient's standpoint in a representative French …
Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy.
Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, Carrié A. Couvert P, et al. Pharmacogenomics. 2008 Sep;9(9):1217-27. doi: 10.2217/14622416.9.9.1217. Pharmacogenomics. 2008. PMID: 18781850 Clinical Trial.
Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study.
Simon D, Detournay B, Eschwege E, Bouée S, Bringer J, Attali C, Dejager S. Simon D, et al. Diabetes Ther. 2014 Jun;5(1):207-24. doi: 10.1007/s13300-014-0064-0. Epub 2014 Apr 12. Diabetes Ther. 2014. PMID: 24729158 Free PMC article.
Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
Michiels Y, Bugnon O, Chicoye A, Dejager S, Moisan C, Allaert FA, Hunault C, Romengas L, Méchin H, Vergès B. Michiels Y, et al. Among authors: dejager s. Adv Ther. 2019 Jun;36(6):1291-1303. doi: 10.1007/s12325-019-00957-y. Epub 2019 May 2. Adv Ther. 2019. PMID: 31049873 Free PMC article. Clinical Trial.
90 results
Jump to page
Feedback